Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP500675.RAtD44PlbL7rssJfN6COZngJRNwUdm6gg8RHyfojfpQio130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP500675.RAtD44PlbL7rssJfN6COZngJRNwUdm6gg8RHyfojfpQio130_assertion type Assertion NP500675.RAtD44PlbL7rssJfN6COZngJRNwUdm6gg8RHyfojfpQio130_head.
- NP500675.RAtD44PlbL7rssJfN6COZngJRNwUdm6gg8RHyfojfpQio130_assertion description "[We conclude that DEK-CAN molecular monitoring by RQ-PCR in t(6;9) malignancies is a useful tool for individual patient management and that molecular negativity is indispensable for survival, but should not be a prerequisite for allografting in this rare, poor prognosis, subset of AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP500675.RAtD44PlbL7rssJfN6COZngJRNwUdm6gg8RHyfojfpQio130_provenance.
- NP500675.RAtD44PlbL7rssJfN6COZngJRNwUdm6gg8RHyfojfpQio130_assertion evidence source_evidence_literature NP500675.RAtD44PlbL7rssJfN6COZngJRNwUdm6gg8RHyfojfpQio130_provenance.
- NP500675.RAtD44PlbL7rssJfN6COZngJRNwUdm6gg8RHyfojfpQio130_assertion SIO_000772 15973457 NP500675.RAtD44PlbL7rssJfN6COZngJRNwUdm6gg8RHyfojfpQio130_provenance.
- NP500675.RAtD44PlbL7rssJfN6COZngJRNwUdm6gg8RHyfojfpQio130_assertion wasDerivedFrom befree-2016 NP500675.RAtD44PlbL7rssJfN6COZngJRNwUdm6gg8RHyfojfpQio130_provenance.
- NP500675.RAtD44PlbL7rssJfN6COZngJRNwUdm6gg8RHyfojfpQio130_assertion wasGeneratedBy ECO_0000203 NP500675.RAtD44PlbL7rssJfN6COZngJRNwUdm6gg8RHyfojfpQio130_provenance.